Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink
Objective To develop and validate a prognostic model for risk-stratified monitoring of 5-aminosalicylate nephrotoxicity.Methods This UK retrospective cohort study used data from the Clinical Practice Research Datalink Aurum and Gold for model development and validation respectively. It included adul...
Saved in:
Main Authors: | Abhishek Abhishek, Richard D Riley, Christian D Mallen, Guruprasad P Aithal, Georgina Nakafero, Matthew J Grainge, Maarten W Taal, Tim Card, Matthew D Stevenson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/12/1/e001627.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study
by: Abhishek Abhishek, et al.
Published: (2024-05-01) -
Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
by: M. Campieri, et al.
Published: (1989-01-01) -
Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review
by: C.N. Williams
Published: (1987-01-01) -
Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
by: Andrew W Kirkpatrick, et al.
Published: (1999-01-01) -
Antineoplastic Effects of 5-Aminosalicylates and Potential Cancer Preventive Role in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (2004-01-01)